查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2023-2030 年全球手術敷料市場
市場調查報告書
商品編碼
1380415

2023-2030 年全球手術敷料市場

Global Surgical Dressing Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

預計全球手術敷料市場在預測期內（2023-2030）將以CAGR6.4% 成長。腿部靜脈潰瘍、壓瘡和糖尿病足潰瘍等慢性傷口的流行，給傷口護理專業人員帶來了越來越大的挑戰，對外科敷料行業的成長產生了相當大的影響。根據美國疾病管制與預防中心 (CDC) 的數據，超過 3,700 萬美國人患有糖尿病，另外 9,600 萬美國成年人患有糖尿病前期，這使他們面臨 2 型糖尿病的風險。大約 25% 的糖尿病患者傷口癒合不良，這可能導致下肢被切除，並產生嚴重的經濟和心理後果。高血糖環境會促進生物膜的生長，並使治療糖尿病傷口變得困難。糖尿病可引起嚴重的併發症，包括心臟病、腎衰竭和失明。 2022年10月，根據澳洲衛生和老年護理部發布的報告，該部門在2019-2021年的三年內目標投資120萬澳元用於傷口管理。慢性傷口在澳洲是一個嚴重問題，每年醫院和住宅護理機構中估計有 40 萬例慢性傷口。

此外，根據美國國立衛生研究院 (NIH) 的數據，慢性不癒合傷口 (CNHW) 通常與糖尿病、血管缺陷、高血壓和慢性腎臟病等合併症有關。結果增加了對手術敷料的需求。此外，美國食品藥物管理局 (FDA) 批准數量的增加也歸因於手術敷料的日益普及。 2023 年4 月，3M Health Care 的創新3M (TM) Veraflo (TM) 療法，包括3M (TM) Veraflo (TM) Cleanse Choice Complete (TM) 敷料和3M (TM) VAC Veraflo (TM) Cleanse Choice (TM ) 敷料，已收到首次獲得美國食品藥物管理局(FDA) 批准，可透過流體機械方式去除感染性物質、非活性組織和傷口碎片，從而減少所需的手術清創次數，同時促進肉芽組織形成，創造促進傷口癒合的環境。

目錄

第 1 章：報告摘要

  • 目前行業分析及成長潛力展望
  • 研究方法和工具
  • 市場區隔
    • 按細分
    • 按地區

第 2 章：市場概述與見解

  • 報告範圍
  • 分析師見解和當前市場趨勢
    • 主要發現
    • 建議
    • 結論

第 3 章：競爭格局

  • 主要公司分析
  • 3M Co.
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • ConvaTec Group Plc
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • Johnson & Johnson Services, Inc.
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • Smith & Nephew Plc
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • 關鍵策略分析

第 4 章：市場細分

  • 按類型分類的全球手術敷料市場
    • 膠原蛋白敷料
    • 透明薄膜敷料
    • 海藻酸鹽敷料
    • 泡棉敷料
    • 紗布敷料
    • 銀敷料
    • 其他（水凝膠敷料、複合敷料）
  • 全球手術敷料市場（按應用）
    • 心血管疾病（CVD）
    • 糖尿病手術
    • 移植部位
    • 潰瘍
    • 伯恩斯
  • 按最終用戶分類的全球手術敷料市場
    • 醫院
    • 門診手術中心
    • 專科診所
    • 家庭醫療保健

第 5 章：區域分析

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 歐洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 世界其他地區

第 6 章：公司簡介

  • Abigo Medical AB
  • B. Braun SE
  • Baxter Healthcare Corp.,
  • Cardinal Health Inc.
  • Coloplast A/S
  • ConvaTec Group Plc
  • Derma Sciences Inc. (Integra LifeSciences)
  • Essity Aktiebolag AB,
  • Medline Industries Inc.
  • Medtronic Plc
  • Molnlycke Health Care AB
  • Molnlycke Health Care AB,
  • Narang Medical Ltd
  • Organogenesis Holdings Inc.,
  • Sanara MedTech, Inc.,
Product Code: OMR2027824

Title: Global Surgical Dressing Market Size, Share & Trends Analysis Report by Type (Collagen Dressings, Transparent Film Dressings, Alginate Dressings, Foam Dressings, Gauze Dressings, Silver Dressings, and Others), by Application (Cardiovascular Diseases (CVD), Diabetes Based Surgeries, Transplant Sites, Ulcers, and Burns), and by End-User (Hospitals, Ambulatory Surgery Centers, Specialty Clinics, and Home Healthcare)Forecast Period (2023-2030).

The global surgical dressing market is anticipated to grow at a CAGR of 6.4% during the Forecast Period (2023-2030). The prevalence of chronic wounds, such as venous leg ulcers, pressure ulcers, and diabetic foot ulcers, is increasing challenges to wound care professionals, having a considerable impact on the growth of the surgical dressing industry. According to the Centers for Disease Control and Prevention (CDC), more than 37 million Americans have diabetes, and another 96 million adults in the US have a condition called prediabetes, which puts them at risk for type 2 diabetes. About 25% of individuals with diabetes mellitus have poor wound healing, which can lead to the removal of lower limbs and has significant financial and psychological consequences. The hyperglycemic environment encourages the growth of biofilms and makes it challenging to treat diabetic wounds. Diabetes can cause serious complications, including heart disease, kidney failure, and blindness. In October 2022, according to the report published by the Australian Department of Health and Aged Care, the department made a targeted investment of $1.20 million over three years from 2019-2021 for wound management. Chronic wounds are a significant problem in Australia, with an estimated 400,000 cases in hospital and residential care settings yearly.

Furthermore, according to the National Institute of Health (NIH), chronic non-healing wounds (CNHW) are typically correlated with comorbidities such as diabetes, vascular deficits, hypertension, and chronic kidney disease. The result has increased the demand for surgical dressing. Furthermore, the rising number of food and drug administration (FDA) clearance also attributed to the increasing adoption of surgical dressing. In April 2023, 3M Health Care's innovative 3M™ Veraflo™ Therapy, with both 3M™ Veraflo™ Cleanse Choice Complete™ Dressing and 3M™ V.A.C. Veraflo Cleanse Choice™ Dressing, received the first-ever Food and Drug Administration (FDA) clearance for hydromechanical removal of infectious materials, non-viable tissue and wound debris which reduces the number of surgical debridement required, while promoting granulation tissue formation, creating an environment that promotes wound healing.

Segmental Outlook

The global surgical dressing market is segmented on the type, application, and end-user. Based on the type, the market is sub-segmented into collagen dressings, transparent film dressings, alginate dressings, foam dressings, gauze dressings, silver dressings, and others. Further, other types of surgical dressing include hydrogel dressings, composites dressings. Based on the application, the market is sub-segmented into cardiovascular diseases, diabetes-based surgeries, transplant sites, ulcers, and burns. Further, based on the end-user, the market is sub-segmented into hospitals, ambulatory surgery centers, specialty clinics and home healthcare. Among the type, the transparent film dressings sub-segment is anticipated to hold a considerable share of the market, owing to the maintaining wound moisture and reducing infection rates.

The Hospitals Sub-Segment is Anticipated to Hold a Considerable Share of the Global Surgical Dressing Market

Among the end-user, the hospitals sub-segment is expected to hold a considerable share of the global surgical dressing market. The segmental growth is attributed to the growing number of surgical procedures, increasing occurrence of diabetic foot ulcers, and rising number of hospitals. Hospitals provide services such as admitted patient care, including for elective surgery, emergency department care, and outpatient (non-admitted patient) care. As per the latest survey by the American Hospital Association (AH), the total number of hospitals in the US was counted ware 6,129 in 2023. Moreover, according to the Australian Institute of Health and Welfare, the number of hospitalizations in Australia has increased. In In 2021-22, there were 11.6 million hospitalizations, covering 31.8 million days of patient care, 59.0% (6.8 million) of hospitalizations were in public hospitals, accounting for 68.0.% of days of patient care (21.7 million). There are 41.0% (4.8 million) of hospitalizations were in private hospitals, accounting for 32.0% of days of patient care (10.0 million). Thus, with a growing number of hospitals, and hospitalization cases, the segment is projected to grow significantly over the forecast period.

Regional Outlook

The global surgical dressing market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Europe is anticipated to hold a prominent share of the market across the globe, owing to the increasing prevalence of diabetes, increasing R&D and growing medical tourism industry.

The Asia-Pacific Region is Expected to Grow at a Significant CAGR in the Global Surgical Dressing Market

Among all regions, the Asia-Pacific region is anticipated to grow at a considerable CAGR over the forecast period. China dominates the Asia-Pacific surgical dressing market followed by India, Japan, South Korea, and the rest of the Asia-Pacific economies. The surgical dressing market in China is experiencing growth owing to rising number of surgeries, rising number of cardiovascular disease-related surgeries, and increasing prevalence of chronic disorders, such as diabetes. According to the World Health Organization, China has the highest number of diabetic patients globally, with nearly 116 million active cases in 2019, and is expected to increase to 150 million by 2040. The estimated diabetes prevalence rate in China in 2009 was 3.9% and is projected to increase to 5.4% by 2030. The prevalence of diabetes in Chinese adults aged 20-79 years is projected to increase from 8.2% to 9.7% during 2020-2030. The expansion and emergence of the wound care management sector by Chinese players such as Winner Medical, Covalon, and others contribute to the market's growth. For instance, in June 2022, Winner Medical displayed its latest and industry-leading advanced wound care solutions at the EWMA 2022 conference. At the conference, Winner Medical also launched a new product such as transparent film dressing, bordered silicone foam dressing with SAF and antibiosis series products and its new product, the CMC dressing. Winner Medical's wound care products have been widely used in more than 110 countries as primary solutions to provide wound management for acute and chronic wounds resulting from diabetes, immobility, and venous disease, as well as from traumatic injury, burns, invasive surgery, and other causes.

Market Players Outlook

The major companies serving the global surgical dressing market include: 3M Co., ConvaTec Group Plc, Johnson & Johnson Services, Inc., Smith & Nephew Plc, Abigo Medical AB, B. Braun SE, Baxter Healthcare Corp., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in January 2022, Convatec Group Plc, a global medical solutions company focused on the management of chronic conditions, entered into a definitive agreement to acquire Triad Life Sciences Inc., a US-focused medical device company that develops biologically derived innovative products to address unmet clinical needs in surgical wounds, chronic wounds and burns.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global surgical dressing market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. 3M Co.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. ConvaTec Group Plc
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Johnson & Johnson Services, Inc.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Smith & Nephew Plc
    • 3.5.1. Overview
    • 3.5.2. Financial Analysis
    • 3.5.3. SWOT Analysis
    • 3.5.4. Recent Developments
  • 3.6. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Surgical Dressing Market by Type
    • 4.1.1. Collagen Dressings
    • 4.1.2. Transparent Film Dressings
    • 4.1.3. Alginate Dressings
    • 4.1.4. Foam Dressings
    • 4.1.5. Gauze Dressings
    • 4.1.6. Silver Dressings
    • 4.1.7. Other (Hydrogel Dressings, Composites Dressings)
  • 4.2. Global Surgical Dressing Market by Application
    • 4.2.1. Cardiovascular Diseases (CVD)
    • 4.2.2. Diabetes Based Surgeries
    • 4.2.3. Transplant Sites
    • 4.2.4. Ulcers
    • 4.2.5. Burns
  • 4.3. Global Surgical Dressing Market by End-User
    • 4.3.1. Hospitals
    • 4.3.2. Ambulatory Surgery Centers
    • 4.3.3. Specialty Clinics
    • 4.3.4. Home Healthcare

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Abigo Medical AB
  • 6.2. B. Braun SE
  • 6.3. Baxter Healthcare Corp.,
  • 6.4. Cardinal Health Inc.
  • 6.5. Coloplast A/S
  • 6.6. ConvaTec Group Plc
  • 6.7. Derma Sciences Inc. (Integra LifeSciences)
  • 6.8. Essity Aktiebolag AB,
  • 6.9. Medline Industries Inc.
  • 6.10. Medtronic Plc
  • 6.11. Molnlycke Health Care AB
  • 6.12. Molnlycke Health Care AB,
  • 6.13. Narang Medical Ltd
  • 6.14. Organogenesis Holdings Inc.,
  • 6.15. Sanara MedTech, Inc.,

LIST OF TABLES

  • 1. GLOBAL SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 2. GLOBAL COLLAGEN DRESSINGS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL TRANSPARENT FILM DRESSINGS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL ALGINATE DRESSINGS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL FOAM DRESSINGS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL GAUZE DRESSINGS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL SILVER DRESSINGS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL OTHER TYPES OF SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY APPLIACTION, 2022-2030 ($ MILLION)
  • 10. GLOBAL SURGICAL DRESSING FOR CARDIOVASCULAR DISEASES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. GLOBAL SURGICAL DRESSING FOR DIABETES BASED SURGERIES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL SURGICAL DRESSING FOR TRANSPLANT SITES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. GLOBAL SURGICAL DRESSING FOR ULCERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 14. GLOBAL SURGICAL DRESSING FOR BURNS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 15. GLOBAL SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 16. GLOBAL SURGICAL DRESSING IN HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 17. GLOBAL SURGICAL DRESSING IN AMBULATORY SURGICAL CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 18. GLOBAL SURGICAL DRESSING IN SPECIALTY CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 19. GLOBAL SURGICAL DRESSING IN HOME HEALTHCARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 20. GLOBAL SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 21. NORTH AMERICAN SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 22. NORTH AMERICAN SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 23. NORTH AMERICAN SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 24. NORTH AMERICAN SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 25. EUROPEAN SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 26. EUROPEAN SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 27. EUROPEAN SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 28. EUROPEAN SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 29. ASIA-PACIFIC SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 30. ASIA-PACIFIC SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 31. ASIA-PACIFIC SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 32. ASIA-PACIFIC SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 33. REST OF THE WORLD SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 34. REST OF THE WORLD SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 35. REST OF THE WORLD SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL SURGICAL DRESSING MARKET SHARE BY TYPE, 2022 VS 2030 (%)
  • 2. GLOBAL COLLAGEN DRESSINGS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL TRANSPARENT FILM DRESSINGS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL ALGINATE DRESSINGS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL FOAM DRESSINGS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL GAUZE DRESSINGS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL SILVER DRESSINGS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL OTHER TYPES OF SURGICAL DRESSING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL SURGICAL DRESSING MARKET SHARE BY APPLICATION, 2022 VS 2030 (%)
  • 10. GLOBAL SURGICAL DRESSING FOR CARDIOVASCULAR DISEASES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL SURGICAL DRESSING FOR DIABETES BASED SURGERIES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL SURGICAL DRESSING FOR TRANSPLANT SITES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 13. GLOBAL SURGICAL DRESSING FOR ULCERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 14. GLOBAL SURGICAL DRESSING FOR BURNS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 15. GLOBAL SURGICAL DRESSING MARKET SHARE BY END-USER, 2022 VS 2030 (%)
  • 16. GLOBAL SURGICAL DRESSING IN HOSPITALS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 17. GLOBAL SURGICAL DRESSING IN AMBULATORY SURGICAL CENTERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 18. GLOBAL SURGICAL DRESSING IN SPECIALTY CLINICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 19. GLOBAL SURGICAL DRESSING IN HOME HEALTHCARE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 20. GLOBAL SURGICAL DRESSING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 21. US SURGICAL DRESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. CANADA SURGICAL DRESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. UK SURGICAL DRESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. FRANCE SURGICAL DRESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. GERMANY SURGICAL DRESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. ITALY SURGICAL DRESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. SPAIN SURGICAL DRESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. REST OF EUROPE SURGICAL DRESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 29. INDIA SURGICAL DRESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 30. CHINA SURGICAL DRESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 31. JAPAN SURGICAL DRESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 32. SOUTH KOREA SURGICAL DRESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 33. REST OF ASIA-PACIFIC SURGICAL DRESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 34. REST OF THE WORLD SURGICAL DRESSING MARKET SIZE, 2022-2030 ($ MILLION)